Explore detailed financial insights for NSE: Neogen Chemicals Limited, including share price, quarterly results, governance, and stock forecasts for 2025.

NSE: Neogen Chemicals Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept

Stay informed with the latest announcements for Neogen, including updates on board meetings and corporate actions.

NEOGEN
Neogen Chemicals Limited - https://www.neogenchem.com
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds, unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; and advance intermediates; as well as chemistries, such as alkylation, acylation, aminatin, oxidation, dehalogenation, silylation, halex reaction, friedel craft, couplings, and chlorination; custom synthesis; and contract manufacturing services. It serves pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavours and fragrances, and specialty polymers industries, as well as vapour absorption chillers. The company also exports its products to 31 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.

Neogen Chemicals Limited Share Price Today

1,851.00
OPEN
1,883.10
HIGH
1,831.50
LOW
1,843.50
CLOSE
18 K
VOLUME
5,305 Cr
Market Cap
64041
Average Volume
Basic Materials
Sector
NSI
Exchange

Neogen Chemicals Limited Share Analysis & 2025 Insights

// -->

Investor Presentations

Date Description Download
SIP
Lumpsum
₹25,000
12%
10 Yr

Invested Amount: ₹

Estimated Returns: ₹

Total Value: ₹

NSE: NEOGEN Stock Actions

Company
Symbol
ISIN
Subject
Ex Date
Face Value
Broadcast Date
Neogen Chemicals Limited
NEOGEN
INE136S01016
Annual General Meeting/Dividend - Rs 2 Per Share
19 Sep 2024
10
N/A
Neogen Chemicals Limited
NEOGEN
INE136S01016
Extra Ordinary General Meeting
20 Oct 2023
10
N/A
Neogen Chemicals Limited
NEOGEN
INE136S01016
Annual General Meeting/Dividend - Rs 3 Per Share
25 Aug 2023
10
N/A
Neogen Chemicals Limited
NEOGEN
INE136S01016
Annual General Meeting/Dividend - Rs 2.75 Per Share
19 Sep 2022
10
N/A
Neogen Chemicals Limited
NEOGEN
INE136S01016
Extra-Ordinary General Meting
23 Dec 2021
10
N/A

NSE: NEOGEN Recent Announcements

Symbol
Date
Description
Industry
NEOGEN
01 Jan 2025, 15:41:50
Updates
N/A
NEOGEN
27 Dec 2024, 10:47:44
Trading Window-XBRL
N/A
NEOGEN
27 Dec 2024, 10:46:46
Trading Window
N/A
NEOGEN
10 Dec 2024, 11:29:41
Analysts/Institutional Investor Meet/Con. Call Updates
N/A
NEOGEN
10 Dec 2024, 11:22:03
Analysts/Institutional Investor Meet/Con. Call Updates
N/A

NSE: NEOGEN Corporate Governance

Name
Symbol
Timestamp
Submission Date
XBRL Document
Neogen Chemicals Limited
NEOGEN
19 Oct 2024, 15:25:00
19 Oct 2024, 15:25:00
Neogen Chemicals Limited
NEOGEN
19 Jul 2024, 17:33:00
19 Jul 2024, 17:33:00
Neogen Chemicals Limited
NEOGEN
20 Apr 2024, 11:52:00
20 Apr 2024, 12:15:00
Neogen Chemicals Limited
NEOGEN
20 Jan 2024, 21:45:00
20 Jan 2024, 22:15:00
Neogen Chemicals Limited
NEOGEN
23 Nov 2023, 16:45:00
23 Nov 2023, 17:15:00

NSE: NEOGEN Detailed Governance

Category
Date of Birth
Date of Initial Appointment
DIN
Director Name
Status
Chairperson & Executive Director-MD
30 Sep 1945
07 Mar 1989
00185487
HARIDAS THAKARSHI KANANI
Active
Executive Director-MD
18 Oct 1976
15 Jul 2013
05136947
HARIN HARIDAS KANANI
Active
Independent Director
20 Oct 1950
25 Sep 2012
00002817
SANJAY MEHTA
Active
Independent Director
15 Nov 1965
15 Sep 2014
00367482
HITESH BHARATKUMAR RESHAMWALA
Active
Executive Director
30 Sep 1953
27 Jul 2015
07274873
SHYAMSUNDER RADHESHYAM UPADHYAY
Active

NSE: NEOGEN Board Meetings

Purpose
Symbol
Industry
ISIN
Name
Time
Board Meeting Intimation
NEOGEN
N/A
INE136S01016
Neogen Chemicals Limited
06 Nov 2024, 16:25:06
Financial Results
NEOGEN
N/A
INE136S01016
Neogen Chemicals Limited
01 Aug 2024, 18:52:39
Financial Results/Dividend
NEOGEN
N/A
INE136S01016
Neogen Chemicals Limited
24 Apr 2024, 21:18:02
Financial Results
NEOGEN
N/A
INE136S01016
Neogen Chemicals Limited
01 Feb 2024, 18:10:03
NEOGEN CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 08-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 .
NEOGEN
N/A
INE136S01016
Neogen Chemicals Limited
01 Nov 2023, 17:44:09

NSE: NEOGEN Event Calendar

Purpose
Symbol
Industry
ISIN
Name
Time
Description
Financial Results
NEOGEN
-
INE136S01016
Neogen Chemicals Limited
06 Nov 2024, 00:00:00
To consider and approve the financial results for the period ended September 30, 2024
Financial Results
NEOGEN
-
INE136S01016
Neogen Chemicals Limited
01 Aug 2024, 00:00:00
To consider and approve the financial results for the period ended Jun 30, 2024
Financial Results/Dividend
NEOGEN
-
INE136S01016
Neogen Chemicals Limited
24 Apr 2024, 00:00:00
To consider and approve the financial results for the period ended March 31, 2024 and dividend
Financial Results
NEOGEN
-
INE136S01016
Neogen Chemicals Limited
01 Feb 2024, 00:00:00
To consider and approve the financial results for the period ended December 31, 2023
Financial Results
NEOGEN
-
INE136S01016
Neogen Chemicals Limited
01 Nov 2023, 00:00:00
To consider and approve the financial results for the period ended September 30, 2023

NSE: NEOGEN Balance Sheet Data In (Cr)

date period_type Ordinary Shares Number Share Issued Net Debt Total Debt Tangible Book Value Invested Capital Working Capital Net Tangible Assets Capital Lease Obligations Common Stock Equity Total Capitalization Total Equity Gross Minority Interest Stockholders Equity Other Equity Interest Retained Earnings Additional Paid In Capital Capital Stock Common Stock Total Liabilities Net Minority Interest Total Non Current Liabilities Net Minority Interest Other Non Current Liabilities Non Current Pension And Other Postretirement Benefit Plans Non Current Accrued Expenses Tradeand Other Payables Non Current Non Current Deferred Revenue Non Current Deferred Taxes Liabilities Long Term Debt And Capital Lease Obligation Long Term Capital Lease Obligation Long Term Debt Long Term Provisions Current Liabilities Other Current Liabilities Current Deferred Taxes Liabilities Current Debt And Capital Lease Obligation Current Capital Lease Obligation Current Debt Pensionand Other Post Retirement Benefit Plans Current Current Provisions Payables Other Payable Dividends Payable Total Tax Payable Accounts Payable Total Assets Total Non Current Assets Other Non Current Assets Non Current Prepaid Assets Financial Assets Investmentin Financial Assets Available For Sale Securities Long Term Equity Investment Investmentsin Joint Venturesat Cost Goodwill And Other Intangible Assets Other Intangible Assets Net PPE Accumulated Depreciation Gross PPE Construction In Progress Other Properties Machinery Furniture Equipment Buildings And Improvements Land And Improvements Properties Current Assets Other Current Assets Hedging Assets Current Restricted Cash Prepaid Assets Inventory Other Inventories Finished Goods Work In Process Raw Materials Other Receivables Taxes Receivable Accounts Receivable Allowance For Doubtful Accounts Receivable Gross Accounts Receivable Cash Cash Equivalents And Short Term Investments Other Short Term Investments Cash And Cash Equivalents Cash Equivalents Cash Financial
2024-09-30T00:00:00 quarterly 26,381,674.00 26,381,674.00 4,970,100,000.00 5,342,800,000.00 7,761,700,000.00 12,804,600,000.00 2,052,600,000.00 7,761,700,000.00 310,100,000.00 7,771,900,000.00 9,194,200,000.00 7,771,900,000.00 7,771,900,000.00 7,508,100,000.00 0.00 0.00 263,800,000.00 263,800,000.00 7,731,400,000.00 2,054,100,000.00 0.00 0.00 0.00 0.00 0.00 246,300,000.00 1,679,300,000.00 257,000,000.00 1,422,300,000.00 105,300,000.00 5,677,300,000.00 158,800,000.00 39,900,000.00 3,663,500,000.00 53,100,000.00 3,610,400,000.00 0.00 15,300,000.00 1,501,700,000.00 0.00 0.00 0.00 1,501,700,000.00 15,503,300,000.00 7,773,400,000.00 1,145,100,000.00 0.00 0.00 122,300,000.00 122,300,000.00 0.00 0.00 10,200,000.00 0.00 6,495,800,000.00 0.00 6,495,800,000.00 1,308,100,000.00 5,187,700,000.00 0.00 0.00 0.00 0.00 7,729,900,000.00 392,200,000.00 0.00 0.00 0.00 4,010,100,000.00 0.00 0.00 0.00 0.00 6,300,000.00 0.00 2,222,600,000.00 0.00 0.00 1,098,700,000.00 1,036,100,000.00 62,600,000.00 0.00 0.00
2024-03-31T00:00:00 annual 26,381,674.00 26,381,674.00 3,813,000,000.00 4,089,200,000.00 7,591,400,000.00 11,538,200,000.00 2,566,900,000.00 7,591,400,000.00 153,900,000.00 7,602,900,000.00 8,845,200,000.00 7,602,900,000.00 7,602,900,000.00 7,339,100,000.00 1,981,500,000.00 5,219,800,000.00 263,800,000.00 263,800,000.00 7,011,100,000.00 1,741,400,000.00 100,000.00 90,700,000.00 0.00 36,500,000.00 0.00 237,300,000.00 1,376,800,000.00 134,500,000.00 1,242,300,000.00 90,700,000.00 5,269,700,000.00 56,900,000.00 34,600,000.00 2,712,400,000.00 19,400,000.00 2,693,000,000.00 13,100,000.00 13,100,000.00 2,475,500,000.00 994,900,000.00 0.00 34,600,000.00 1,446,000,000.00 14,614,000,000.00 6,777,400,000.00 -200,000.00 721,900,000.00 0.00 112,300,000.00 112,300,000.00 4,500,000.00 4,500,000.00 11,500,000.00 11,500,000.00 6,034,000,000.00 -641,500,000.00 6,675,500,000.00 1,089,100,000.00 660,600,000.00 2,703,000,000.00 838,000,000.00 1,384,800,000.00 0.00 7,836,600,000.00 365,300,000.00 2,400,000.00 27,900,000.00 307,100,000.00 3,824,400,000.00 36,900,000.00 767,400,000.00 2,652,000,000.00 368,100,000.00 733,000,000.00 0.00 2,816,900,000.00 -9,000,000.00 2,825,900,000.00 124,900,000.00 2,600,000.00 122,300,000.00 0.00 122,300,000.00
2024-03-31T00:00:00 quarterly 26,381,674.00 26,381,674.00 3,813,000,000.00 4,089,200,000.00 7,591,400,000.00 11,538,200,000.00 2,566,900,000.00 7,591,400,000.00 153,900,000.00 7,602,900,000.00 8,845,200,000.00 7,602,900,000.00 7,602,900,000.00 7,339,100,000.00 1,981,500,000.00 5,219,800,000.00 263,800,000.00 263,800,000.00 7,011,100,000.00 1,741,400,000.00 100,000.00 90,700,000.00 0.00 36,500,000.00 0.00 237,300,000.00 1,376,800,000.00 134,500,000.00 1,242,300,000.00 90,700,000.00 5,269,700,000.00 56,900,000.00 34,600,000.00 2,712,400,000.00 19,400,000.00 2,693,000,000.00 13,100,000.00 13,100,000.00 2,475,500,000.00 994,900,000.00 0.00 34,600,000.00 1,446,000,000.00 14,614,000,000.00 6,777,400,000.00 -200,000.00 721,900,000.00 0.00 112,300,000.00 112,300,000.00 4,500,000.00 4,500,000.00 11,500,000.00 11,500,000.00 6,034,000,000.00 -641,500,000.00 6,675,500,000.00 1,089,100,000.00 660,600,000.00 2,703,000,000.00 838,000,000.00 1,384,800,000.00 0.00 7,836,600,000.00 365,300,000.00 2,400,000.00 27,900,000.00 307,100,000.00 3,824,400,000.00 36,900,000.00 767,400,000.00 2,652,000,000.00 368,100,000.00 733,000,000.00 0.00 2,816,900,000.00 -9,000,000.00 2,825,900,000.00 124,900,000.00 2,600,000.00 122,300,000.00 0.00 122,300,000.00
2023-09-30T00:00:00 quarterly 24,939,316.00 24,939,316.00 4,587,800,000.00 4,790,700,000.00 4,961,600,000.00 9,591,400,000.00 1,975,700,000.00 4,961,600,000.00 173,600,000.00 4,974,300,000.00 6,321,400,000.00 4,974,300,000.00 4,974,300,000.00 4,724,900,000.00 0.00 0.00 249,400,000.00 249,400,000.00 7,045,800,000.00 1,798,900,000.00 0.00 0.00 0.00 0.00 0.00 210,400,000.00 1,484,900,000.00 137,800,000.00 1,347,100,000.00 69,400,000.00 5,246,900,000.00 27,300,000.00 30,300,000.00 3,305,800,000.00 35,800,000.00 3,270,000,000.00 0.00 33,400,000.00 1,666,900,000.00 0.00 0.00 0.00 1,666,900,000.00 12,020,100,000.00 4,797,500,000.00 76,000,000.00 0.00 0.00 5,200,000.00 101,700,000.00 0.00 0.00 12,700,000.00 0.00 4,606,200,000.00 0.00 4,606,200,000.00 1,006,000,000.00 3,600,200,000.00 0.00 0.00 0.00 0.00 7,222,600,000.00 374,300,000.00 0.00 0.00 0.00 3,475,100,000.00 0.00 0.00 0.00 0.00 6,900,000.00 0.00 2,267,800,000.00 0.00 0.00 1,098,500,000.00 1,069,200,000.00 29,300,000.00 0.00 0.00
2023-03-31T00:00:00 annual 24,939,316.00 24,939,316.00 3,439,900,000.00 3,695,100,000.00 4,811,100,000.00 8,447,300,000.00 2,460,900,000.00 4,811,100,000.00 73,000,000.00 4,825,200,000.00 6,116,000,000.00 4,825,200,000.00 4,825,200,000.00 4,575,800,000.00 1,699,800,000.00 2,766,400,000.00 249,400,000.00 249,400,000.00 5,712,800,000.00 1,615,400,000.00 -900,000.00 46,500,000.00 0.00 37,600,000.00 0.00 190,200,000.00 1,341,100,000.00 50,300,000.00 1,290,800,000.00 46,500,000.00 4,097,400,000.00 15,400,000.00 17,600,000.00 2,354,000,000.00 22,700,000.00 2,331,300,000.00 20,800,000.00 20,800,000.00 1,720,000,000.00 136,900,000.00 0.00 17,600,000.00 1,565,500,000.00 10,538,000,000.00 3,979,700,000.00 -100,000.00 139,300,000.00 0.00 82,200,000.00 82,200,000.00 7,500,000.00 7,500,000.00 14,100,000.00 14,100,000.00 3,818,900,000.00 -417,000,000.00 4,235,900,000.00 358,400,000.00 483,300,000.00 2,241,000,000.00 782,100,000.00 371,100,000.00 0.00 6,558,300,000.00 -100,000.00 -1,400,000.00 0.00 547,900,000.00 2,929,700,000.00 55,400,000.00 588,900,000.00 1,909,400,000.00 376,000,000.00 340,700,000.00 0.00 1,773,800,000.00 -9,000,000.00 1,782,700,000.00 967,600,000.00 785,400,000.00 182,200,000.00 0.00 182,200,000.00
2023-03-31T00:00:00 quarterly 24,939,316.00 24,939,316.00 3,439,900,000.00 3,695,100,000.00 4,811,100,000.00 8,447,300,000.00 2,460,900,000.00 4,811,100,000.00 73,000,000.00 4,825,200,000.00 6,116,000,000.00 4,825,200,000.00 4,825,200,000.00 4,575,800,000.00 1,699,800,000.00 2,766,400,000.00 249,400,000.00 249,400,000.00 5,712,800,000.00 1,615,400,000.00 -900,000.00 46,500,000.00 0.00 37,600,000.00 0.00 190,200,000.00 1,341,100,000.00 50,300,000.00 1,290,800,000.00 46,500,000.00 4,097,400,000.00 15,400,000.00 17,600,000.00 2,354,000,000.00 22,700,000.00 2,331,300,000.00 20,800,000.00 20,800,000.00 1,720,000,000.00 136,900,000.00 0.00 17,600,000.00 1,565,500,000.00 10,538,000,000.00 3,979,700,000.00 -100,000.00 139,300,000.00 0.00 82,200,000.00 82,200,000.00 7,500,000.00 7,500,000.00 14,100,000.00 14,100,000.00 3,818,900,000.00 -417,000,000.00 4,235,900,000.00 358,400,000.00 483,300,000.00 2,241,000,000.00 782,100,000.00 371,100,000.00 0.00 6,558,300,000.00 -100,000.00 -1,400,000.00 0.00 547,900,000.00 2,929,700,000.00 55,400,000.00 588,900,000.00 1,909,400,000.00 376,000,000.00 340,700,000.00 0.00 1,773,800,000.00 -9,000,000.00 1,782,700,000.00 967,600,000.00 785,400,000.00 182,200,000.00 0.00 182,200,000.00
2022-03-31T00:00:00 annual 24,939,316.00 24,939,316.00 1,919,300,000.00 2,287,500,000.00 4,391,600,000.00 6,640,500,000.00 2,741,900,000.00 4,391,600,000.00 40,200,000.00 4,393,200,000.00 5,608,400,000.00 4,393,200,000.00 4,393,200,000.00 4,143,000,000.00 1,267,800,000.00 2,766,400,000.00 249,400,000.00 249,400,000.00 3,601,100,000.00 1,418,400,000.00 -800,000.00 40,400,000.00 0.00 38,000,000.00 0.00 106,100,000.00 1,234,700,000.00 19,500,000.00 1,215,200,000.00 40,400,000.00 2,182,700,000.00 22,000,000.00 2,600,000.00 1,052,800,000.00 20,700,000.00 1,032,100,000.00 18,700,000.00 18,700,000.00 1,067,800,000.00 79,000,000.00 0.00 0.00 988,800,000.00 7,994,300,000.00 3,069,700,000.00 -100,000.00 100,800,000.00 0.00 94,500,000.00 94,500,000.00 9,700,000.00 9,700,000.00 1,600,000.00 1,600,000.00 2,956,000,000.00 -280,700,000.00 3,236,700,000.00 106,200,000.00 384,800,000.00 1,729,300,000.00 645,300,000.00 371,100,000.00 0.00 4,924,600,000.00 219,200,000.00 39,100,000.00 124,200,000.00 219,200,000.00 1,945,900,000.00 23,700,000.00 119,100,000.00 1,411,800,000.00 391,300,000.00 365,600,000.00 0.00 1,095,000,000.00 -2,100,000.00 1,097,100,000.00 1,135,600,000.00 807,600,000.00 328,000,000.00 0.00 328,000,000.00
2021-03-31T00:00:00 annual 23,334,606.00 23,334,606.00 2,154,900,000.00 2,217,400,000.00 1,826,900,000.00 3,990,200,000.00 622,200,000.00 1,826,900,000.00 57,400,000.00 1,830,200,000.00 2,991,200,000.00 1,830,200,000.00 1,830,200,000.00 1,596,893,000.00 881,700,000.00 605,600,000.00 233,300,000.00 233,300,000.00 3,089,400,000.00 1,310,000,000.00 -100,000.00 30,300,000.00 0.00 20,000,000.00 0.00 81,600,000.00 1,178,200,000.00 17,200,000.00 1,161,000,000.00 30,269,000.00 1,779,400,000.00 18,003,000.00 9,900,000.00 1,039,200,000.00 40,200,000.00 999,000,000.00 11,200,000.00 11,171,000.00 716,800,000.00 56,000,000.00 0.00 0.00 660,800,000.00 4,919,600,000.00 2,518,000,000.00 -100,000.00 96,900,000.00 0.00 80,929,000.00 80,929,000.00 7,500,000.00 7,500,000.00 3,300,000.00 3,300,000.00 2,410,400,000.00 -166,700,000.00 2,577,100,000.00 1,146,500,000.00 220,900,000.00 659,600,000.00 179,000,000.00 371,100,000.00 0.00 2,401,600,000.00 1,000.00 5,800,000.00 7,000,000.00 214,100,000.00 1,140,300,000.00 4,600,000.00 56,200,000.00 786,700,000.00 292,800,000.00 243,800,000.00 0.00 785,500,000.00 -500,000.00 786,000,000.00 5,100,000.00 256,625,000.00 5,100,000.00 0.00 5,100,000.00

NSE: NEOGEN Cash Flow Data In (Cr)

date period_type Free Cash Flow Repayment Of Debt Issuance Of Debt Issuance Of Capital Stock Capital Expenditure End Cash Position Other Cash Adjustment Outside Changein Cash Beginning Cash Position Effect Of Exchange Rate Changes Changes In Cash Financing Cash Flow Net Other Financing Charges Interest Paid Cff Cash Dividends Paid Common Stock Dividend Paid Net Common Stock Issuance Common Stock Issuance Net Issuance Payments Of Debt Net Long Term Debt Issuance Long Term Debt Payments Long Term Debt Issuance Investing Cash Flow Net Other Investing Changes Interest Received Cfi Net Investment Purchase And Sale Sale Of Investment Purchase Of Investment Net Business Purchase And Sale Sale Of Business Net Intangibles Purchase And Sale Sale Of Intangibles Purchase Of Intangibles Net PPE Purchase And Sale Sale Of PPE Purchase Of PPE Operating Cash Flow Taxes Refund Paid Change In Working Capital Change In Other Current Liabilities Change In Other Current Assets Change In Payable Change In Inventory Change In Receivables Other Non Cash Items Provisionand Write Offof Assets Depreciation And Amortization Amortization Cash Flow Depreciation Gain Loss On Investment Securities Net Foreign Currency Exchange Gain Loss Gain Loss On Sale Of PPE Net Income From Continuing Operations
2024-03-31T00:00:00 annual -3,319,200,000.00 -352,900,000.00 666,200,000.00 2,466,500,000.00 -3,027,700,000.00 125,000,000.00 0.00 207,000,000.00 0.00 -82,000,000.00 2,365,300,000.00 0.00 -420,600,000.00 -74,800,000.00 0.00 2,466,500,000.00 2,466,500,000.00 313,300,000.00 313,300,000.00 -352,900,000.00 666,200,000.00 -2,155,800,000.00 0.00 73,100,000.00 0.00 0.00 0.00 35,200,000.00 35,200,000.00 -100,000.00 0.00 -100,000.00 -3,027,600,000.00 0.00 -3,027,600,000.00 -291,500,000.00 -97,500,000.00 -1,287,600,000.00 943,700,000.00 -151,800,000.00 -108,900,000.00 -894,700,000.00 -1,075,900,000.00 420,600,000.00 0.00 228,700,000.00 2,800,000.00 225,900,000.00 -73,100,000.00 -10,400,000.00 0.00 527,700,000.00
2023-03-31T00:00:00 annual -1,340,900,000.00 -899,900,000.00 2,260,800,000.00 0.00 -1,037,400,000.00 207,000,000.00 0.00 452,200,000.00 0.00 -245,200,000.00 1,002,900,000.00 0.00 -289,400,000.00 -68,600,000.00 0.00 0.00 0.00 1,360,900,000.00 1,360,900,000.00 -899,900,000.00 2,260,800,000.00 -944,600,000.00 37,500,000.00 44,200,000.00 47,000,000.00 47,000,000.00 0.00 0.00 0.00 -12,500,000.00 0.00 -12,500,000.00 -1,024,900,000.00 0.00 -1,024,900,000.00 -303,500,000.00 -115,200,000.00 -1,359,000,000.00 63,300,000.00 -300,700,000.00 532,000,000.00 -983,800,000.00 -669,800,000.00 289,400,000.00 3,100,000.00 162,000,000.00 0.00 162,000,000.00 -44,200,000.00 50,100,000.00 0.00 710,300,000.00
2022-03-31T00:00:00 annual -1,688,700,000.00 -430,400,000.00 388,800,000.00 2,250,000,000.00 -1,702,800,000.00 452,200,000.00 0.00 12,100,000.00 0.00 440,100,000.00 1,884,300,000.00 -7,700,000.00 -190,800,000.00 -52,500,000.00 0.00 2,250,000,000.00 2,250,000,000.00 -41,600,000.00 -41,600,000.00 -430,400,000.00 388,800,000.00 -1,458,300,000.00 1,400,000.00 9,400,000.00 -807,600,000.00 0.00 -807,600,000.00 0.00 0.00 1,700,000.00 1,700,000.00 0.00 -661,300,000.00 1,041,500,000.00 -1,702,800,000.00 14,100,000.00 -98,000,000.00 -700,800,000.00 181,000,000.00 -163,200,000.00 398,600,000.00 -805,600,000.00 -311,600,000.00 190,800,000.00 2,100,000.00 116,900,000.00 0.00 116,900,000.00 4,100,000.00 -70,600,000.00 -1,100,000.00 570,700,000.00
2021-03-31T00:00:00 annual -514,700,000.00 -282,400,000.00 978,400,000.00 0.00 -1,350,400,000.00 12,100,000.00 0.00 14,800,000.00 0.00 -2,700,000.00 507,300,000.00 -4,300,000.00 -137,700,000.00 -46,700,000.00 0.00 0.00 0.00 696,000,000.00 696,000,000.00 -282,400,000.00 978,400,000.00 -1,345,700,000.00 0.00 1,300,000.00 0.00 0.00 0.00 0.00 0.00 -200,000.00 0.00 -200,000.00 -1,350,200,000.00 0.00 -1,350,200,000.00 835,700,000.00 -103,700,000.00 365,900,000.00 88,500,000.00 -216,200,000.00 368,900,000.00 158,400,000.00 -33,700,000.00 137,700,000.00 500,000.00 69,000,000.00 0.00 69,000,000.00 -9,300,000.00 -66,500,000.00 0.00 442,100,000.00
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 1,000.00 0.00 0.00 0.00 0.00 -17,592,000.00 0.00 0.00 -43,017,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,170,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2,076,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 653,000.00 0.00

NSE: NEOGEN Income Statement Data In (Cr)

date period_type Tax Effect Of Unusual Items Tax Rate For Calcs Normalized EBITDA Total Unusual Items Total Unusual Items Excluding Goodwill Net Income From Continuing Operation Net Minority Interest Reconciled Depreciation Reconciled Cost Of Revenue EBITDA EBIT Net Interest Income Interest Expense Interest Income Normalized Income Net Income From Continuing And Discontinued Operation Total Expenses Rent Expense Supplemental Diluted Average Shares Basic Average Shares Diluted EPS Basic EPS Diluted NI Availto Com Stockholders Net Income Common Stockholders Otherunder Preferred Stock Dividend Net Income Net Income Including Noncontrolling Interests Net Income Continuous Operations Tax Provision Pretax Income Other Non Operating Income Expenses Net Non Operating Interest Income Expense Total Other Finance Cost Interest Expense Non Operating Interest Income Non Operating Operating Income Operating Expense Other Operating Expenses Depreciation And Amortization In Income Statement Amortization Depreciation Income Statement Research And Development Selling General And Administration Selling And Marketing Expense General And Administrative Expense Rent And Landing Fees Gross Profit Cost Of Revenue Total Revenue Operating Revenue
2024-03-31T00:00:00 annual 0.00 0.00 113.42 0.00 0.00 35.65 22.87 404.08 113.42 90.55 -34.65 37.78 7.41 35.65 35.65 545.49 3.84 2.55 2.55 0.00 0.00 35.65 35.65 0.00 35.65 35.65 35.65 17.12 52.77 0.06 -34.65 4.28 37.78 7.41 87.18 141.41 60.11 22.87 0.28 22.59 3.49 30.46 17.73 12.73 3.84 228.59 404.08 632.67 632.67
2023-03-31T00:00:00 annual 0.00 0.00 110.93 0.00 0.00 49.97 16.20 406.84 110.93 94.73 -25.11 23.70 3.83 49.97 49.97 565.06 2.99 2.49 2.49 0.00 0.00 49.97 49.97 0.00 49.97 49.97 49.97 21.06 71.03 0.62 -25.11 5.24 23.70 3.83 95.42 158.22 70.22 16.20 0.30 15.90 4.70 30.74 20.27 10.47 2.99 253.64 406.84 660.48 660.48
2022-03-31T00:00:00 annual 0.09 0.00 86.17 0.39 0.39 44.63 11.69 309.82 86.56 74.87 -18.48 17.80 0.60 44.33 44.63 400.04 0.00 2.49 2.49 0.00 0.00 44.63 44.63 0.00 44.63 44.63 44.63 12.44 57.07 0.08 -18.48 1.28 17.80 0.60 74.90 90.22 29.84 11.69 0.00 11.69 4.70 16.24 6.63 9.61 0.00 165.12 309.82 474.94 474.94
2021-03-31T00:00:00 annual 0.00 0.00 64.04 0.00 0.00 31.33 6.90 239.43 64.04 57.14 -13.64 12.93 0.13 31.33 31.33 279.24 0.00 2.33 2.33 0.00 0.00 31.33 31.33 0.00 31.33 31.33 31.33 12.88 44.21 0.01 -13.64 0.84 12.93 0.13 57.17 39.81 17.00 6.90 0.00 6.90 0.00 12.84 5.05 7.79 0.00 96.98 239.43 336.41 336.41
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

FII & DII Data (In Cr)

Date FII Gross Purchase FII Gross Sales FII Net Purchase / Sales DII Gross Purchase DII Gross Sales DII Net Purchase / Sales
2025-02-03 12,505.92 16,464.29 -3,958.37 19,319.48 16,611.25 2,708.23
2025-01-30 10,513.63 15,096.58 -4,582.95 13,934.35 11,768.46 2,165.89
2025-01-29 7,644.40 10,230.83 -2,586.43 12,871.38 11,078.67 1,792.71
2025-01-27 9,488.57 14,504.03 -5,015.46 16,503.43 9,861.28 6,642.15
2025-01-24 11,230.47 13,988.96 -2,758.49 12,835.41 10,433.10 2,402.31
2025-01-23 13,316.55 18,779.07 -5,462.52 14,412.73 10,700.18 3,712.55
2025-01-22 12,936.64 16,962.89 -4,026.25 15,437.18 11,796.96 3,640.22
Quarterly Results
Profit & Loss
Piotroski F-Score
5/9
0 1 2 3 4 5 6 7 8 9

Key Metrics

EPS

15.3

P/E

131.25163

P/B

6.96817

Dividend Yield

0.1%

Market Cap

5,305.01 Cr.

Face Value

288.189

Book Value

288.189

ROE

5.3%

EBITDA Growth

113.67 Cr.

Debt/Equity

53.785

Short Term

Subscribe to unlock this feature

Medium Term

Subscribe to unlock this feature

Long Term

Subscribe to unlock this feature

Yearly Stock Performance Heatmap

Latest Updates

NEOGEN News

Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI

Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:50

NEOGEN News

Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends

"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:47

NEOGEN News

FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore

Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:37

NEOGEN News

Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal

The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:23

NEOGEN News

Apple iPhone SE 4: Price To Features, 11 Things You Need To Know

iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:12

NEOGEN News

Rupee Closed Weaker Against The US Dollar

The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 15:54

NEOGEN News

Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45

Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:09

NEOGEN News

War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel

The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:00

Popular Questions

How to Buy neogen Shares on Fincept?

You can buy Neogen Chemicals Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.

What is the Market Cap of neogen?

The market capitalization of Neogen Chemicals Limited is ₹5,305 Cr as of 05 Feb 2025.

What are the PE and PB ratios of Neogen Chemicals Limited?

The PE and PB ratios of Neogen Chemicals Limited are Not Available and 6.96817 respectively as of 05 Feb 2025.

What is the 52 Week High of Neogen Chemicals Limited?

The 52-week high of Neogen Chemicals Limited is ₹2420 as of 05 Feb 2025.

What is the 52 Week Low of Neogen Chemicals Limited?

The 52-week low of Neogen Chemicals Limited is ₹1176 as of 05 Feb 2025.

What are the earnings per share (EPS) for Neogen Chemicals Limited?

The Earnings Per Share (EPS) of Neogen Chemicals Limited is ₹15.3 as per the most recent quarterly results available on Fincept.

What is the ROE (Return on Equity) of Neogen Chemicals Limited?

The Return on Equity (ROE) of Neogen Chemicals Limited is 5.3% as per the most recent financial year data. Explore more on Fincept.

SEYAIND

View Stock

UNIONBANK

View Stock

EQUIPPP

View Stock

POONAWALLA

View Stock

ADVENZYMES

View Stock

SPYL

View Stock

MATRIMONY

View Stock

JYOTHYLAB

View Stock

NECCLTD

View Stock

SHRIRAMPPS

View Stock

BANARBEADS

View Stock

JSFB

View Stock

HTMEDIA

View Stock

VERTOZ

View Stock

LTTS

View Stock